• No results found

Rosiglitazone attenuates the age related changes in astrocytosis and the deficit in LTP

N/A
N/A
Protected

Academic year: 2020

Share "Rosiglitazone attenuates the age related changes in astrocytosis and the deficit in LTP"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1. (A, B) T1 relaxation time was significantly increased in the hippocampus of aged (n �between young (n0.05; ANOVA); there is a partial attenuation of this age-related increase in T1 relaxation time by rosiglitazone in that there was no significant dif
Fig. 2. Expression of CD11b (A), CD68 (B), CD40R (C) and MHCII (D) were significantly increased in hippocampal tissue prepared from aged, compared with
Fig. 3. (A) LTP in perforant path-granule cell synapses in urethane-anesthetized rats was reduced in aged control-treated rats compared withLine graphs show representative epsps pre-HFS and of the last 10 minuteof recordings for (i) young control, (ii) you
Fig. 4. (A) GFAP mRNA was significantly increased in the hippocampusof aged, control-treated rats (**GFAP immunoreactivity was markedly increased in sections of hippocam-pus prepared from aged, control-treated (iii), compared with young, con-attenuated in a
+4

References

Related documents

Relative to HRT continuers, discontinuers aged 85 and older experienced apparent HRQOL improvements following cessation, with fewer days in which physical health was not good (p

Similarly the significant age-related increases in CD11b and MHCII, and the chemokines, MCP-1 and IP-10 (p < 0.01 or p < 0.001; ANOVA; Figure 3D-G), which are chemotactic for

MnSOD activity in the liver and brain mitochondria of aged animals was significantly higher compared to the values obtained from young rats (p<0.05 and 0.001,